Marinus Pharmace Stock Price, News & Analysis
Company Description
Marinus Pharmace (NASDAQ: MRNS) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $30.0M, ranking #5,912 among all listed U.S. companies by market cap.
MRNS stock has declined 94.6% over the past year. Shares last traded at $0.5500.
This page provides a comprehensive overview of MRNS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Marinus Pharmace (MRNS) stock last traded at $0.5500. Over the past 12 months, the stock has lost 94.6%. At a market capitalization of $30.0M, MRNS is classified as a micro-cap stock with approximately 55.2M shares outstanding.
Latest News
Marinus Pharmace has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, earnings, clinical trial, conferences. View all MRNS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MRNS Company Profile & Sector Positioning
Marinus Pharmace (MRNS) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.